The Wire · All news

Zantac / Ranitidine (NDMA Cancer)

Zantac-Related Search Terms Spike Sharply on Google Trends

Published Updated

By People's Justice

What happened

Google Trends data detected week-over-week surges in several Zantac-related search terms around June 24, 2026. Searches for 'zantac lawsuit attorneys' rose 250%, 'ndma' rose 250%, and 'ranitidine' rose 100%. Terms including 'recall on zantac,' 'zantac lawsuit update 2021,' and 'zantac lawsuit update 2022' were flagged as BREAKOUT trends, meaning search volume increased so sharply that a standard percentage could not be calculated.

Event date:

Source: trends.google.com

Related news

  1. Zantac / Ranitidine (NDMA Cancer)

  2. Zantac / Ranitidine (NDMA Cancer)

    Public Search Interest in Zantac Lawsuit Topics Spikes

    Google Trends data detected sharp increases in searches for terms including 'ranitidine' (up 300%), 'zantac lawsuit attorneys' (up 150%), and 'ndma' (up 170%), along with breakout search activity for 'zantac lawsuit update 2022' and 'recall on zantac,' according to Google Trends.

    Source: trends.google.com

  3. Zantac / Ranitidine (NDMA Cancer)

    MDL 2924 (S.D. Fla., Judge Robin L. Rosenberg) omnibus Daubert order (Doc 6120, 341 pages): ALL defendants' Daubert motions on general causation GRANTED and defendants' summary judgment motion GRANTED — plaintiffs 'fail to produce admissible primary evidence of general causation' that ranitidine causes cancer, ending the federal MDL claims.

    MDL 2924 (S.D. Fla., Judge Robin L. Rosenberg) omnibus Daubert order (Doc 6120, 341 pages): ALL defendants' Daubert motions on general causation GRANTED and defendants' summary judgment motion GRANTED — plaintiffs 'fail to produce admissible primary evidence of general causation' that ranitidine causes cancer, ending the federal MDL claims. Verified from the court order itself.

    Source: gsk.com